AzTrials
AzTrials

Vitamin d DeficiencyVIDISNCT04637880

25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

An observational study of Vitamin d Deficiency and Preeclampsia, run by Medical University of Vienna at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders Hypothesis: Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
How many people
249 participants
Where
1 siteAustria
Study dates
Jul 2012to 1 Jul 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: healthy pregnant women

Who may be able to join

  • age> 18 years
  • informed consent

Who cannot join

  • chronic hypertension
  • kidney disease
  • lupus erythematodes
  • diabetes mellitus
  • malabsorption syndrome
  • hyperparathyroidism
  • surgery on the thyroid gland

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Department of Obstetrics and fetomaternal Medicine, Medical University of Vienna

    Vienna, 1090

Other trials in Austria

About this study

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders

Hypothesis:

Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Medical subject headings
Vitamin D Deficiency, Pre-Eclampsia, Premature Birth, Hypertension, Pregnancy-Induced, Diabetes, Gestational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 25- Hydroxyvitamin D and relation to development of preeclampsia

    Measured: over course of pregnancy

Secondary outcomes (1)
  1. 25 Hydroxyvitamin D in newborn

    Measured: once at delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2020
  2. Study startJul 2012
  3. Primary completionJul 2018
  4. Study completion1 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
249 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04637880
Sponsor's protocol ID
V02
Acronym
VIDIS
Status last verified
Nov 2020
First submitted
21 Jun 2014
Last updated
20 Nov 2020
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Vitamin d Deficiency and Preeclampsia, run by Medical University of Vienna at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

25- Hydroxyvitamin D and relation to development of preeclampsia (time frame: over course of pregnancy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in